Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat.

Deltamethrin (DLT) is a type II pyrethroid insecticide widely used in agriculture and public health. DLT is a potent neurotoxin that is primarily cleared from the body by metabolism. To better understand the dosimetry of DLT in the central nervous system, a physiologically based pharmacokinetic (PBPK) model for DLT was constructed for the adult, male Sprague-Dawley rat that employed both flow-limited (brain, gastrointestinal [GI] tract, liver, and rapidly perfused tissues) and diffusion-limited (fat, blood/plasma, and slowly perfused tissues) rate equations. The blood was divided into plasma and erythrocytes. Cytochrome P450-mediated metabolism was accounted for in the liver and carboxylesterase (CaE)-mediated metabolism in plasma and liver. Serial blood, brain, and fat samples were taken for DLT analysis for up to 48 h after adult rats received 2 or 10 mg DLT/kg po. Hepatic biotransformation accounted for approximately 78% of these administered doses. Plasma CaEs accounted for biotransformation of approximately 8% of each dosage. Refined PBPK model forecasts compared favorably to the 2- and 10-mg/kg po blood, plasma, brain, and fat DLT profiles, as well as profiles subsequently obtained from adult rats given 1 mg/kg iv. DLT kinetic profiles extracted from published reports of oral and iv experiments were also used for verification of the model's simulations. There was generally good agreement in most instances between predicted and the limited amount of empirical data. It became clear from our modeling efforts that there is considerably more to be learned about processes that govern GI absorption and exsorption, transport, binding, brain uptake and egress, fat deposition, and systemic elimination of DLT and other pyrethroids. The current model can serve as a foundation for construction of models for other pyrethroids and can be improved as more definitive information on DLT kinetic processes becomes available.

[1]  Hyo Jung Kim,et al.  Rapid determination of the synthetic pyrethroid insecticide, deltamethrin, in rat plasma and tissues by HPLC. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  T. R. Sterner,et al.  The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat. , 2002, Toxicology and applied pharmacology.

[3]  S. Jayalakshmi,et al.  Identification of factors responsible for insecticide resistance in Helicoverpa armigera. , 2004, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[4]  K. Rozman,et al.  Effect of partial jejunectomy and colectomy on the disposition of hexachlorobenzene in rats treated or not treated with hexadecane. , 1985, Toxicology and applied pharmacology.

[5]  L. Reiter,et al.  Age-dependent differences in the susceptibility of rats to deltamethrin. , 1994, Toxicology and applied pharmacology.

[6]  K M Crofton,et al.  Relative potencies for acute effects of pyrethroids on motor function in rats. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  J. Casida,et al.  Decamethrin metabolites from oxidative, hydrolytic, and conjugative reactions in mice. , 1979, Journal of agricultural and food chemistry.

[8]  A. Callaghan,et al.  Evidence for p‐glycoprotein modification of insecticide toxicity in mosquitoes of the Culex pipiens complex , 2002, Medical and veterinary entomology.

[9]  D. Wohlers,et al.  Toxicological profile for pyrethrins and pyrethroids , 2003 .

[10]  M E Andersen,et al.  Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[11]  K Krishnan,et al.  A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicals , 1995, Human & experimental toxicology.

[12]  D. H. Hutson,et al.  Metabolism of cis- and trans-cypermethrin in rats. Balance and tissue retention study. , 1981, Journal of agricultural and food chemistry.

[13]  J. Casida,et al.  Decamethrin metabolism in rats. , 1978, Journal of agricultural and food chemistry.

[14]  J. Fisher,et al.  Characterization of deltamethrin metabolism by rat plasma and liver microsomes. , 2006, Toxicology and applied pharmacology.

[15]  J. Casida,et al.  Golden age of insecticide research: past, present, or future? , 1998, Annual review of entomology.

[16]  Jin-Sung Choi,et al.  Structure-activity relationships for the action of 11 pyrethroid insecticides on rat Na v 1.8 sodium channels expressed in Xenopus oocytes. , 2006, Toxicology and applied pharmacology.

[17]  S. Cole,et al.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. , 2005, Toxicology and applied pharmacology.

[18]  A. Anadón,et al.  Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat. , 1996, Toxicology and applied pharmacology.

[19]  E. Laws,et al.  Handbook of pesticide toxicology , 1991 .

[20]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[21]  J. Casida,et al.  Effects of pyrethroid structure on rates of hydrolysis and oxidation by mouse liver microsomal enzymes , 1977 .

[22]  P. Okunieff,et al.  Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes. , 2001, Blood cells, molecules & diseases.

[23]  K. Crofton,et al.  Vehicle and route dependent effects of a pyrethroid insecticide, deltamethrin, on motor function in the rat. , 1995, Neurotoxicology and teratology.

[24]  R. Armstrong,et al.  Distribution of cardiac output during diurnal changes of activity in rats. , 1991, The American journal of physiology.

[25]  M. Andersen,et al.  Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  Dana Sargent,et al.  Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. , 2002, Toxicology.

[27]  J E Simmons,et al.  Organ weights and fat volume in rats as a function of strain and age. , 1999, Journal of toxicology and environmental health. Part A.

[28]  J. Casida,et al.  Pyrethroid toxicology: Mouse intracerebral structure-toxicity relationships , 1982 .

[29]  J. Rickard,et al.  The toxicokinetics of deltamethrin in rats after intravenous administration of a toxic dose , 1982 .

[30]  D. M. Soderlund,et al.  Structure-activity relationships for the action of 11 pyrethroid insecticides on rat Na v 1.8 sodium channels expressed in Xenopus oocytes. , 2006, Toxicology and applied pharmacology.

[31]  J. Casida,et al.  Analysis and persistence of permethrin, cypermethrin, deltamethrin, and fenvalerate in the fat and brain of treated rats. , 1982, Journal of agricultural and food chemistry.

[32]  Christopher J Endres,et al.  The role of transporters in drug interactions. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[33]  J. Rickard,et al.  Correlation of blood and brain levels of the neurotoxic pyrethroid deltamethrin with the onset of symptoms in rats , 1985 .